Does Inhibition of Nuclear Factor Kappa B Explain the Protective Effect of Ticagrelor on Myocardial Ischemia-Reperfusion Injury?

Yochai Birnbaum; Yumei Ye; Jose Regino Perez-Polo

doi:10.1097/FJC.0000000000000787

Does Inhibition of Nuclear Factor Kappa B Explain the Protective Effect of Ticagrelor on Myocardial Ischemia-Reperfusion Injury?

Yochai Birnbaum, Yumei Ye, Jose Regino Perez-Polo

Biochemistry & Molecular Biology

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	108-111
Number of pages	4
Journal	Journal of cardiovascular pharmacology
Volume	75
Issue number	2
DOIs	https://doi.org/10.1097/FJC.0000000000000787
State	Published - Feb 1 2020

ASJC Scopus subject areas

Pharmacology
Cardiology and Cardiovascular Medicine

Access to Document

10.1097/FJC.0000000000000787

Cite this

@article{8970298d09b14d8e93276ef3bf1a07bb,

title = "Does Inhibition of Nuclear Factor Kappa B Explain the Protective Effect of Ticagrelor on Myocardial Ischemia-Reperfusion Injury?",

author = "Yochai Birnbaum and Yumei Ye and Perez-Polo, {Jose Regino}",

year = "2020",

month = feb,

day = "1",

doi = "10.1097/FJC.0000000000000787",

language = "English (US)",

volume = "75",

pages = "108--111",

journal = "Journal of cardiovascular pharmacology",

issn = "0160-2446",